Modica M, Santagati M, Guccione S, Russo F, Cagnotto A, Goegan M, Mennini T
Dipartimento di Scienze Farmaceutiche, Università di Catania, viale A. Doria 6, 95125, Catania, Italy.
Eur J Med Chem. 2000 Dec;35(12):1065-79. doi: 10.1016/s0223-5234(00)01187-9.
This work reports the synthesis and the binding tests on the 5-HT(3) and 5-HT(4) receptors of new thienopyrimidopiperazine and piperazinylacylaminodimethylthiophene derivatives, in order to identify potent and selective ligands for each receptor. The compound with higher affinity and selectivity for the 5-HT(3) over the 5-HT(4) receptor was the 3-amino-2-(4-benzyl-1-piperazinyl)-5,6-dimethyl-thieno[2,3-d]pyrimidin-4(3H)-one 28 (5-HT(3) K(i)=3.92 nM, 5-HT(4) not active), the compound with higher affinity and selectivity for the 5-HT(4) over the 5-HT(3) receptor was the 2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butanoylamino]-4,5-dimethyl-3-thiophenecarboxylic acid ethyl ester 41 (5-HT(4) K(i)=81.3 nM, 5-HT(3) not active). Conformational analyses were carried out on the compounds of the piperazinylacylaminodimethylthiophene series (39-42) taking compound 41 as the template.
本研究报告了新型噻吩并嘧啶哌嗪和哌嗪基酰氨基二甲基噻吩衍生物对5-HT(3)和5-HT(4)受体的合成及结合试验,以确定对每个受体具有强效和选择性的配体。对5-HT(3)受体亲和力和选择性高于5-HT(4)受体的化合物是3-氨基-2-(4-苄基-1-哌嗪基)-5,6-二甲基-噻吩并[2,3-d]嘧啶-4(3H)-酮28(5-HT(3) K(i)=3.92 nM,对5-HT(4)无活性),对5-HT(4)受体亲和力和选择性高于5-HT(3)受体的化合物是2-[4-[4-(2-嘧啶基)-1-哌嗪基]丁酰氨基]-4,5-二甲基-3-噻吩羧酸乙酯41(5-HT(4) K(i)=81.3 nM,对5-HT(3)无活性)。以化合物41为模板,对哌嗪基酰氨基二甲基噻吩系列化合物(39-42)进行了构象分析。